NIH F30 Grants — Individual Predoctoral MD/PhD Fellowship

Recent F30 awards from NIH RePORTER

Examples of funded F30 projects across the last two fiscal years. The matching-award count comes from the full result set; funding totals, averages, rankings, and examples use the first 500 records returned by NIH RePORTER. Figures reflect a snapshot last refreshed on June 9, 2026.

Example F30 projects from the sample

• SPARKLED: Do After School Programs Affect Risk in Kids of Latent Endothelial Disease

  5F30MD017527-05
  Rebecca Drakowski · UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE · $43,714 · awarded Jun 3, 2026 · NIH

  Project Summary/Abstract PROJECT SUMMARY Cardiovascular complications are the leading cause of maternal mortality in the United States. The burden of poor cardiovascular health largely falls on communities with lower socioeconomic status and limited access to quality care, thus impacting health outcomes. After school care (ASC) can be intentionally designed…

• An Exploration of the Intergenerational Persistence of Health and Social Status Contributing to Racial Disparities in Birth Outcomes in South Carolina

  5F30MD019520-03
  Abigail Kappelman · UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI · $46,714 · awarded Jun 1, 2026 · NIH

  ABSTRACT This project explores how factors across a mother’s life course contribute to adverse birth outcomes such as preterm birth and low birth weight, and how differences in multilevel, intergenerational risk factors (maternal and grandmaternal age, education, and neighborhood income level) and prior health outcomes might explain population differences…

• Neuroinflammatory Alterations in Post-Traumatic Stress Disorder and Chronic Traumatic Encephalopathy

  5F30NS134280-03
  Samantha Calderazzo · BOSTON UNIVERSITY MEDICAL CAMPUS, MA · $48,326 · awarded May 26, 2026 · NIH

  Abstract: Post-traumatic stress disorder (PTSD) is a psychiatric disorder affecting up to 25% of people who have been exposed to a traumatic event characterized by maladaptive anxiety with increased risk for suicide and cognitive impairment. In rodent models of PTSD microglia-mediated synaptic loss has been shown to be a significant contributing factor to…

• Investigating Determinants of Perinatal Lead Exposure, Associations with Preterm Birth, and Reporting Back Research Results

  5F30ES036439-03
  Jasmin Eatman · EMORY UNIVERSITY, GA · $58,114 · awarded May 25, 2026 · NIH

  Lead (Pb) is a naturally occurring metal in the environment, however; biomonitoring and epidemiologic studies have demonstrated that there is no safe level of Pb in humans. Despite this fact, the Centers for Disease Control and Prevention (CDC) identifies documented levels of Pb exposure in most humans, with different levels of Pb exposure across different…

• VGF in the nucleus accumbens: roles in synaptic and opioid-evoked plasticity

  5F30DA060027-03
  Anisha Adke · UNIVERSITY OF MINNESOTA, MN · $55,114 · awarded May 21, 2026 · NIH

  PROJECT SUMMARY Reward neurocircuitry relies in part on endogenous neuropeptide signaling to integrate complex, multivalent information and influence behavior. Opioid addiction can result in neuropeptide imbalances in the nucleus accumbens (NAc), a brain region critical for processing reward. Signaling by neuropeptides derived from VGF (non-acronymic) may…

• Measuring neurodevelopmental effects of genetic risk for Alzheimer's disease via cross-sectional study of brain, cognitive, and physical fitness variables in periadolescent children

  5F30AG084348-03
  Abi Heller-Wight · UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE · $47,020 · awarded May 20, 2026 · NIH

  Project Summary/Abstract As our population ages, Alzheimer’s Disease (AD) and related pathologies will continue to increase in prevalence, making the investigation of modifiable and non-modifiable risk factors related to AD critical. Non- modifiable risk factors, such as genetic risk that individuals are born with, and modifiable risk factors, such as…

• Elucidating the Molecular Mechanism of TRIP13-mediated Radiation Resistance in Oral Squamous Cell Carcinoma

  5F30DE030686-05
  Marsha-Kay Hutchinson · UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI · $32,837 · awarded May 20, 2026 · NIH

  Oral squamous cell carcinoma (OSCC) is a common and aggressive cancer. In recent years, despite significant effort to understand the pathobiology of the disease, there has been only marginal improvement in patient prognosis. Radiation is one of the chief treatment modalities for OSCC, but radiation resistance has led to a high incidence of locoregional…

• Boosting protein synthesis using antisense oligonucleotides to treat neurodegeneration

  5F30AG082394-03
  Ben Boros · WASHINGTON UNIVERSITY, MO · $36,570 · awarded May 19, 2026 · NIH

  PROJECT SUMMARY Brain aging and disease occur alongside the loss of essential proteins and protein functions. For example, thousands of inherited conditions are due to genetic haploinsufficiency, in which partial or complete loss of one normal allele is sufficient to cause disease. Likewise, advanced age involves the loss of protective signaling, such as…

• Interactions between progranulin insufficiency and TDP-43

  5F30AG085889-03
  Anna Cook · UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL · $53,825 · awarded May 19, 2026 · NIH

  PROJECT SUMMARY Frontotemporal Dementia (FTD) is a major cause of early onset dementia and patients can develop a wide range of symptoms including behavioral changes and language impairments. Heterozygous mutations in the progranulin gene (GRN) result in haploinsufficiency of the protein and cause FTD with TDP-43 pathology. TDP- 43 is a RNA binding protein…

• Investigating the Role of AR Extrachromosomal DNA (ecDNA) in Bipolar Androgen Therapy for Advanced Prostate Cancer

  1F30CA314114-01
  Emily Egusa · UNIVERSITY OF MINNESOTA, MN · $44,819 · awarded May 19, 2026 · NIH

  ABSTRACT Prostate cancer is one of the most common malignancies and a leading cause of cancer-related deaths in American men. In advanced prostate cancer, androgen deprivation therapy (ADT) is the standard of care. While most patients initially respond to ADT, they will eventually develop castration resistant prostate cancer (CRPC). CRPC is a lethal and…

• Modulating synovial mechanobiology to mitigate disease progression in osteoarthritis

  5F30AG094106-02
  Elizabeth Bernstein · UNIVERSITY OF PENNSYLVANIA, PA · $55,114 · awarded May 18, 2026 · NIH

  Project Summary Nearly 8% of the global population suffers from osteoarthritis, and the burden of disease is much higher among older adults. Current treatment strategies are limited to symptom management or require invasive surgical procedures that carry significant risk for the elderly. Thus, there is an urgent need for minimally invasive,…

• Role of interleukin-6 signaling on T cell potential of aged hematopoietic stem cells and thymic progenitors

  5F30AG086001-03
  Julia Gensheimer · UNIVERSITY OF CALIFORNIA LOS ANGELES, CA · $35,610 · awarded May 18, 2026 · NIH

  PROJECT SUMMARY/ABSTRACT T cell production declines with age and contributes to decreased immune function and increased susceptibility to infections and cancers in older adults. This decline in T cell output may be due to changes in the aged progenitor cells and/or changes in the thymic microenvironment. T cells develop from hematopoietic stem cells (HSCs)…

Compare nearby NIH grant mechanisms

Searchers often land on F30 while deciding between adjacent NIH activity codes. Compare scope, NIH staff involvement, budget scale, and applicant stage before choosing a funding opportunity.